These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8813576

  • 1. Contrasting effects of SM-9018, a potential atypical antipsychotic, and haloperidol on c-fos mRNA expression in the rat striatum.
    Ishibashi T, Ikeda K, Ishida K, Yasui J, Tojima R, Nakamura M, Ohno Y.
    Eur J Pharmacol; 1996 May 15; 303(3):247-51. PubMed ID: 8813576
    [Abstract] [Full Text] [Related]

  • 2. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP, Dorsa DM.
    Neuroscience; 1999 Mar 15; 89(3):927-38. PubMed ID: 10199625
    [Abstract] [Full Text] [Related]

  • 3. Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
    Ohno Y, Ishibashi T, Okada K, Ishida K, Nakamura M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct 15; 19(6):1091-101. PubMed ID: 8584685
    [Abstract] [Full Text] [Related]

  • 4. Effects of SM-9018, a novel 5-HT2 and D2 receptor antagonist, on electrically-evoked [3H]acetylcholine release from rat striatal slices.
    Ishida K, Ohno Y, Ishibashi T, Nakamura M.
    Gen Pharmacol; 1996 Oct 15; 27(7):1203-7. PubMed ID: 8981068
    [Abstract] [Full Text] [Related]

  • 5. Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone.
    Ohno Y, Ishida-Tokuda K, Ishibashi T, Sakamoto H, Tagashira R, Horisawa T, Yabuuti K, Matsumoto K, Kawabe A, Nakamura M.
    Pol J Pharmacol; 1997 Aug 15; 49(4):213-9. PubMed ID: 9437764
    [Abstract] [Full Text] [Related]

  • 6. Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain.
    Ishibashi T, Tagashira R, Nakamura M, Noguchi H, Ohno Y.
    Pharmacol Biochem Behav; 1999 Aug 15; 63(4):535-41. PubMed ID: 10462181
    [Abstract] [Full Text] [Related]

  • 7. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
    Norman MH, Rigdon GC, Navas F, Cooper BR.
    J Med Chem; 1994 Aug 05; 37(16):2552-63. PubMed ID: 7914539
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of bradykinesia induction by SM-9018, a novel 5-HT2 and D2 receptor antagonist, using the mouse pole test.
    Ohno Y, Ishida K, Ikeda K, Ishibashi T, Okada K, Nakamura M.
    Pharmacol Biochem Behav; 1994 Sep 05; 49(1):19-23. PubMed ID: 7816873
    [Abstract] [Full Text] [Related]

  • 9. The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions.
    Zivin M, Sprah L, Sket D.
    Br J Pharmacol; 1996 Nov 05; 119(6):1187-96. PubMed ID: 8937722
    [Abstract] [Full Text] [Related]

  • 10. Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds.
    Ishizumi K, Kojima A, Antoku F, Saji I, Yoshigi M.
    Chem Pharm Bull (Tokyo); 1995 Dec 05; 43(12):2139-51. PubMed ID: 8582016
    [Abstract] [Full Text] [Related]

  • 11. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.
    Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE.
    Proc Natl Acad Sci U S A; 1992 May 15; 89(10):4270-4. PubMed ID: 1374894
    [Abstract] [Full Text] [Related]

  • 12. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
    Hirose A, Kato T, Ohno Y, Shimizu H, Tanaka H, Nakamura M, Katsube J.
    Jpn J Pharmacol; 1990 Jul 12; 53(3):321-9. PubMed ID: 1975278
    [Abstract] [Full Text] [Related]

  • 14. Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
    Ohno Y, Ishida-Tokuda K, Ishibashi T, Nakamura M.
    Pharmacol Biochem Behav; 1997 Aug 12; 57(4):889-95. PubMed ID: 9259021
    [Abstract] [Full Text] [Related]

  • 15. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
    Merchant KM, Dorsa DM.
    Proc Natl Acad Sci U S A; 1993 Apr 15; 90(8):3447-51. PubMed ID: 8097317
    [Abstract] [Full Text] [Related]

  • 16. The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.
    Fadel J, Dobner PR, Deutch AY.
    Neurosci Lett; 2001 Apr 27; 303(1):17-20. PubMed ID: 11297813
    [Abstract] [Full Text] [Related]

  • 17. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
    Merchant KM.
    Mol Cell Neurosci; 1994 Aug 27; 5(4):336-44. PubMed ID: 7804603
    [Abstract] [Full Text] [Related]

  • 18. Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats.
    Maruoka Y, Ohno Y, Kato T, Hirose A, Tatsuno T, Nakamura M.
    Jpn J Pharmacol; 1993 Aug 27; 62(4):419-22. PubMed ID: 7901446
    [Abstract] [Full Text] [Related]

  • 19. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum.
    Ziólkowska B, Höllt V.
    Neurosci Lett; 1993 Jun 25; 156(1-2):39-42. PubMed ID: 8414186
    [Abstract] [Full Text] [Related]

  • 20. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.
    Wan W, Ennulat DJ, Cohen BM.
    Brain Res; 1995 Aug 07; 688(1-2):95-104. PubMed ID: 8542328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.